Clinical Trial Update: Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse [Phase 2]

View source ↗

Summary

A Phase 2 trial of vinorelbine and cyclophosphamide in patients with refractory or relapsed tumors, including rhabdomyosarcoma, Ewing sarcoma, osteosarcoma, neu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Medulloblastoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Navelbine (vinorelbine)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Rhabdomyosarcomas, Neoplasms, Connective and Soft Tissue | Phase 2 | Status: UNKNOWN